| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 01/18/2001 | WO2001004264A2 Atherosclerosis-associated genes |
| 01/18/2001 | WO2001004151A2 TUBERCULOSIS VACCINE AND DIAGNOSTICS BASED ON THE MYCOBACTERIUM TUBERCULOSIS esat-6 GENE FAMILY |
| 01/18/2001 | WO2001004150A2 Neisseria meningitidis compounds and anti-infection applications thereof |
| 01/18/2001 | WO2001004148A2 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | WO2001004144A2 Fabrication of beta-pleated sheet proteins with specific binding properties |
| 01/18/2001 | WO2001004143A2 Prostase vaccine |
| 01/18/2001 | WO2001004141A2 Seripancrin |
| 01/18/2001 | WO2001004140A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | WO2001004133A1 Human eag2 |
| 01/18/2001 | WO2001004061A1 A biofuel cell using wastewater and active sludge for wastewater treatment |
| 01/18/2001 | WO2001004060A2 Method of purifying water, suitable bacteria for the method and use thereof |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003733A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | WO2001003732A1 Recombinant m. tuberculosis mycobacterium auxotrophic for leucine and vaccines using same |
| 01/18/2001 | WO2001003731A1 Dim mutants of mycobacteria and uses thereof |
| 01/18/2001 | WO2001003730A1 Unmarked deletion mutants of mycobacteria and methods of using same |
| 01/18/2001 | WO2000068383A3 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 01/18/2001 | WO2000063415A8 Dna encoding the human vanilloid receptor vr1 |
| 01/18/2001 | WO2000063378A3 Zalpha13: a human secreted protein |
| 01/18/2001 | WO2000058488A3 Delivery of functional protein sequences by translocating polypeptides |
| 01/18/2001 | WO2000056864A3 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
| 01/18/2001 | WO2000055180A3 Human lung cancer associated gene sequences and polypeptides |
| 01/18/2001 | WO2000032825A3 Development of anti-microbial agents based on bacteriophage genomics |
| 01/18/2001 | WO2000022139A3 Dna sequences for enzymatic synthesis of polyketide or heteropolyketide compounds |
| 01/18/2001 | WO2000002911A3 INTERACTION OF HUMAN BETA AMYLOID PRECURSOR PROTEIN (β-APP) WITH HUMAN LON-PROTEASE LIKE PROTEIN (HSLON) |
| 01/18/2001 | WO1999051756A3 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 01/18/2001 | DE19933288A1 Strukturprotein von Adeno-assoziiertem Virus mit veränderter Antigenität, seine Herstellung und Verwendung Structural protein of adeno-associated virus with altered antigenicity, its preparation and use |
| 01/18/2001 | DE19932688A1 Design von Beta-Faltblatt-Proteinen mit spezifischen Bindungseigenschaften Design of beta-sheet proteins with specific binding properties |
| 01/18/2001 | DE19930676A1 Verfahren zur Stabilisierung von Proteinen in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln A process for the stabilization of proteins in complex mixtures with storage thereof in aqueous solvents |
| 01/18/2001 | CA2383496A1 Compounds for treatment of infectious and immune system disorders and methods for their use |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378985A1 Atherosclerosis-associated genes |
| 01/18/2001 | CA2378875A1 Novel neisseria meningitidis compounds and anti-infection applications thereof |
| 01/18/2001 | CA2378846A1 Prostase vaccine |
| 01/18/2001 | CA2378796A1 Seripancrin |
| 01/18/2001 | CA2378786A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | CA2378763A1 Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family |
| 01/18/2001 | CA2378610A1 Human eag2 |
| 01/18/2001 | CA2378580A1 An electrochemical method for enrichment of microorganism, a biosensor for analyzing organic substance and bod |
| 01/18/2001 | CA2378558A1 A biofuel cell using wastewater and active sludge for wastewater treatment |
| 01/18/2001 | CA2378485A1 Proliferation differentiation factor |
| 01/18/2001 | CA2378452A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | CA2378407A1 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | CA2378240A1 Gamma-herpesvirus dna and methods of use |
| 01/18/2001 | CA2377938A1 Methods and compositions for directed cloning and subcloning using homologous recombination |
| 01/18/2001 | CA2377101A1 Method for stabilizing nitrilase activity and preserving microbial cells |
| 01/18/2001 | CA2374009A1 Glucoamylase variant |
| 01/18/2001 | CA2373534A1 Donor strand complemented pilin and adhesin broad-based vaccines |
| 01/18/2001 | CA2348448A1 Nucleotide sequences for the tal gene |
| 01/18/2001 | CA2348365A1 Nucleotide sequences which code for the opca gene |
| 01/17/2001 | EP1069186A1 Gene encoding desulfurases |
| 01/17/2001 | EP1069136A1 Method for the recombinant production of ribonucleoproteins |
| 01/17/2001 | EP1069135A1 Proteins having immunomodulatory activity and remedies for immunological diseases |
| 01/17/2001 | EP1069133A1 Neisseria meningitidis compounds and anti-infection applications thereof |
| 01/17/2001 | EP1068799A2 Biological models capable of exhibiting secondary disease manifestations |
| 01/17/2001 | EP1068522A1 Antigen |
| 01/17/2001 | EP1068362A1 Hepatitis c virus ns5b compositions and methods of use thereof |
| 01/17/2001 | EP1068337A2 Mammalian gene encoding tolloid-like protein |
| 01/17/2001 | EP1068336A2 Membranemetalloprotease nepii |
| 01/17/2001 | EP1068335A2 Cell cycle regulatory proteins |
| 01/17/2001 | EP1068334A2 Cell cycle regulatory proteins cdc-16, dp-1, dp-2 and e2f from plants |
| 01/17/2001 | EP1068323A2 Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 01/17/2001 | EP1068321A2 A interleukin-1 receptor antagonist and uses thereof |
| 01/17/2001 | EP1068319A1 PEPTIDE LIGAND HAVING SPECIFIC AFFINITY FOR THE HIV1 RETROVIRUS p24 PROTEIN |
| 01/17/2001 | EP1068318A2 Human nucleic acid sequences from prostate tissue |
| 01/17/2001 | EP1068317A2 Human nucleic acid sequences from prostate tumour tissue |
| 01/17/2001 | EP1068315A2 Therapeutic agent for ngf |
| 01/17/2001 | EP1068312A2 5' ests and encoded human proteins |
| 01/17/2001 | EP1068309A2 Enterotoxin-deficient bacillus |
| 01/17/2001 | EP1068308A1 Secreted proteins and polynucleotides encoding them |
| 01/17/2001 | EP1068301A2 Bacterial transglutaminases |
| 01/17/2001 | EP1068295A1 Cell differentiation/proliferation and maintenance factor and uses thereof |
| 01/17/2001 | EP1068294A1 Microbial strains and processes for the manufacture of biomaterials |
| 01/17/2001 | EP1068293A1 Vaccination modalities |
| 01/17/2001 | EP1068241A1 Antibody variants and fragments thereof |
| 01/17/2001 | EP1068238A1 An integrin heterodimer and a subunit thereof |
| 01/17/2001 | EP1068236A1 Human oxidized ldl receptor |
| 01/17/2001 | EP1068231A2 Human nucleic acid sequences of normal ovary tissue |
| 01/17/2001 | EP1068230A1 Chimeric insecticidal protein and gene coding therefore |
| 01/17/2001 | EP1068220A1 nrdF |
| 01/17/2001 | EP1068217A1 Novel molecules of the card-related protein family and uses thereof |
| 01/17/2001 | EP1067945A2 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions |
| 01/17/2001 | EP1067917A2 Method of treating dopaminergic and gaba-nergic disorders |
| 01/17/2001 | EP1067893A2 Human galactosyl transferases |
| 01/17/2001 | EP0696198B1 Novel polypeptide having factor xa inhibitory activity |
| 01/17/2001 | EP0660670B1 Method for preserving fresh meat products and products |
| 01/17/2001 | EP0610396B1 Fingerprinting bacterial strains using repetitive dna sequence amplification |
| 01/17/2001 | CN1280625A Nuclear male sterile plants, method of producing same and method to restore fertility |
| 01/17/2001 | CN1280624A Nucleic and molecules which encode proteins having fructosyl transterase activity and methods for producing long-chain inulin |
| 01/17/2001 | CN1280622A Modification of the tocopherol content of transgenic plants |
| 01/17/2001 | CN1280621A Alkaline protease |
| 01/17/2001 | CN1280619A (Chlamydia trachomatic) genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 01/17/2001 | CN1280618A Protein involved in abscisic acid signalling |
| 01/17/2001 | CN1280615A Expression of endogenous genes by non-homologons recombination of a vactor construct with cellular DNA |
| 01/17/2001 | CN1280614A Recombinational cloning using nucleic acids having recombinatin sites |
| 01/17/2001 | CN1280191A Method for producing nucleic acid inhibiting albumen by inducing and cultivating trichoid root of chinese trichosanthes |
| 01/17/2001 | CN1280188A Continuous producing method of recombined phage in biologicl film reactor |
| 01/17/2001 | CN1280186A New type low temperature akaline protease and its producing method and use and microbe for producing said protease |
| 01/17/2001 | CN1280185A Corynebaclerium for producing L-lysine and method for producing L-lysine |